Results 1 to 10 of about 1,313 (182)

European dermatology forum - updated guidelines on the use of extracorporeal photopheresis 2020 - part 1. [PDF]

Journal of the European Academy of Dermatology and Venereology, Volume 34, Issue 12, Page 2693-2716, December 2020., 2020
Following the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma published in 1983, this technology has received continued use and further recognition for additional earlier as well as ...
Arenberger, P., Arun, A., Assaf, C., Bagot, M., Berlin, G., Bohbot, A., Calzavara-Pinton, P., Child, F., Cho, A., French, L.E., Gennery, A.R., Gniadecki, R., Gollnick, HPM, Greinix, H., Guenova, E., Jaksch, P., Jantschitsch, C., Klemke, C., Knobler, R., Ludvigsson, J., Papadavid, E., Scarisbrick, J., Schwarz, T., Stadler, R., Wolf, P., Zic, J., Zouboulis, C., Zuckermann, A.   +27 more
core   +4 more sources

Extracorporeal Photochemotherapy for Generalized Deep Morphea [PDF]

Archives of Dermatology, 2009
Morphea, or localized scleroderma, can at times constitute a severely disabling and aggressive disease with no single therapy proven to be curative or the standard of care. Herein, we report the case of a patient with severe disabling generalized deep morphea who showed a marked clinical response to treatment with extracorporeal photochemotherapy (ECP).
Jason H. Neustadter, Frank M. Samarin, Kacie R. Carlson, Michael Girardi   +3 more
openalex   +4 more sources

TREATMENT OF THE TUMOR STAGE OF MYCOSIS FUNGOIDES WITH EXTRACORPOREAL PHOTOCHEMOTHERAPY (A CASE DESCRIPT

Alʹmanah Kliničeskoj Mediciny, 2016
The article describes treatment experience with a  tumor stage of mycosis fungoides patient treated with extracorporeal photochemotherapy that showed high clinical efficacy. The patient responded with significant regression of the skin elements after two
V. A. Molochkov, A. V. Kil'dyushevskiy, O. V. Karzanov   +2 more
doaj   +2 more sources

Targeting of T/Tn antigens with a plant lectin to kill human leukemia cells by photochemotherapy. [PDF]

PLoS ONE, 2011
Photochemotherapy is used both for solid tumors and in extracorporeal treatment of various hematologic disorders. Nevertheless, its development in oncology remains limited, because of the low selectivity of photosensitizers (PS) towards human tumor cells.
Guillaume Poiroux, Marguerite Pitié, Raphaël Culerrier, Elodie Lafont, Bruno Ségui, Els J M Van Damme, Willy J Peumans, Jean Bernadou, Thierry Levade, Pierre Rougé, Annick Barre, Hervé Benoist   +11 more
doaj   +6 more sources

Pre-transplant infusion of donor leukocytes treated with extracorporeal photochemotherapy induces immune hypo-responsiveness and long-term allograft survival in murine models [PDF]

Scientific Reports, 2022
Recipients of solid organ transplantation (SOT) rely on life-long immunosuppression (IS), which is associated with significant side effects. Extracorporeal photochemotherapy (ECP) is a safe, existing cellular therapy used to treat transplant rejection by
Jennifer Schneiderman, Longhui Qiu, Xin Yi Yeap, Xin Kang, Feibo Zheng, Junsheng Ye, Yan Xie, Jiao-Jing Wang, Yuvaraj Sambandam, James Mathew, Lin Li, Joseph Leventhal, Richard L. Edelson, Zheng Jenny Zhang   +13 more
doaj   +2 more sources

CLINICAL SIGNIFICANCE OF EXTRACORPOREAL PHOTOCHEMOTHERAPY IN COMPLEX TREATMENT OF LOCALIZED SCLERODERMA

Alʹmanah Kliničeskoj Mediciny, 2016
Background: Scleroderma is an autoimmune disease with progressing lesions of connective tissue where fibrosclerotic and vascular disturbances prevail.
O. A. Fomina, A. V. Molochkov, A. V. Kil’dyushevsky   +2 more
doaj   +2 more sources

EXTRACORPOREAL PHOTOCHEMOTHERAPY IN PSORIASIS AND PSORIATIC ARTHRITIS

Alʹmanah Kliničeskoj Mediciny, 2016
Background: Psoriasis is the most prevalent chronic dermatosis of an autoimmune origin that is characterized by increasing incidence of both severe clinical forms and complications, the most threatening of which is psoriatic arthritis.
E. S. Yakubovskaya, V. A. Molochkov, A. V. Kil'dyushevskiy, O. V. Karzanov   +3 more
doaj   +3 more sources

Extracorporeal photochemotherapy: A potentially useful treatment for scleromyxedema [PDF]

Journal of the American Academy of Dermatology, 1991
Scleromyxedema, a variant of papular mucinosis, is a rare condition that clinically resembles scleroderma. Itis characterized by a lichenoid papular eruption, induration of the skin, and a paraproteinemia of unknown significance. Histologic examination reveals dermal deposition of mucin; proliferation of large, stellate fibroblasts; and fibrosis ...
Michael Berkson, Gerald S. Lazarus, Marie Uberti-Benz, Alain H. Rook   +3 more
openalex   +3 more sources

Current Clinical Applications of Extracorporeal Photochemotherapy [PDF]

Therapeutic Apheresis and Dialysis, 2014
AbstractFrom the 1980s, extracorporeal photochemotherapy (ECP) has been shown to be effective in a variety of pathological conditions such as erythrodermic cutaneous T‐cell lymphoma, autoimmune diseases, solid organ allograft rejection and graft versus host disease.
Maria Capuano, Linda Sommese, Orlando Pignalosa, Delia Parente, Rossella Fabbricini, Giovanni Francesco Nicoletti, Maria Rosaria Pascale, Concetta Schiano, Claudio Napoli   +8 more
openalex   +5 more sources

Extracorporeal photochemotherapy and methotrexate in the treatment of atypical oral lichen planus

Alʹmanah Kliničeskoj Mediciny, 2018
Background: Some authors have successfully used methotrexate in the treatment of atypical oral lichen planus (LP) and noted its good tolerability.
A. V. Molochkov, Yu. V. Molochkova, A. V. Kil'dyushevskiy, A. A. Glazkov   +3 more
doaj   +2 more sources